Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/09/1994 | WO1994012639A2 Interleukin-3 (il-3) mutant polypeptides |
06/09/1994 | WO1994012638A2 Interleukin-3 (il-3) multiple mutation polypeptides |
06/09/1994 | WO1994012637A2 Novel human amyloid protein precursor homologue and kunitz-type inhibitors |
06/09/1994 | WO1994012636A1 Method of controlling polypeptide production in bacteria |
06/09/1994 | WO1994012635A2 Novel seven transmembrane receptors |
06/09/1994 | WO1994012634A1 Neurotrophic factor |
06/09/1994 | WO1994012633A1 Stable oligonucleotides |
06/09/1994 | WO1994012632A1 Improvements in nucleic acid synthesis by pcr |
06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
06/09/1994 | WO1994012630A2 Method for producing polypeptide via bacterial fermentation |
06/09/1994 | WO1994012629A1 Episomal vectors for gene therapy |
06/09/1994 | WO1994012628A1 Cloning and expression of biologically active alpha-galactosidase a |
06/09/1994 | WO1994012627A1 Transgenic animal model for alzheimer's disease |
06/09/1994 | WO1994012626A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
06/09/1994 | WO1994012622A1 Oxalate decarboxylase |
06/09/1994 | WO1994012617A1 Hepatitis b virus vaccines |
06/09/1994 | WO1994012539A1 Multifunctional neurotrophic factors |
06/09/1994 | WO1994012537A2 Granulocyte chemotactic protein |
06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |
06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
06/09/1994 | WO1994012528A1 Subtilin variant of enhanced stability and activity |
06/09/1994 | WO1994012526A1 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3 |
06/09/1994 | WO1994012521A1 Cellular genes encoding retinoblastoma-associated proteins |
06/09/1994 | WO1994012520A1 Linker for linked fusion polypeptides |
06/09/1994 | WO1994012515A1 Methods for treatment of enzyme preparations |
06/09/1994 | WO1994012513A1 Aids therapeutics based on hiv ma peptides |
06/09/1994 | WO1994012216A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
06/09/1994 | WO1994012215A1 Humanized antibodies reactive with l-selectin |
06/09/1994 | WO1994012211A1 Virulence-specific bacterial dna sequence |
06/09/1994 | WO1994012204A1 Anticoagulant proteins |
06/09/1994 | WO1994012162A1 Syndecan stimulation of cellular differentiation |
06/09/1994 | WO1994012015A1 Expression motifs that confer tissue- and developmental-specific expression in plants |
06/09/1994 | WO1994012014A1 Transgenic cotton plants producing heterologous bioplastic |
06/09/1994 | WO1994009159A3 Insertion elements and amplifiable nucleic acids |
06/09/1994 | WO1994009127A3 Supercoiled minicircle dna as as a unitary promoter vector |
06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
06/09/1994 | WO1994005793A3 Dna sequences involved in soraphen biosynthesis by myxobacteria |
06/09/1994 | WO1994005771A3 New bacillus thuringiensis strains and their insecticidal proteins |
06/09/1994 | WO1994004565A3 Ipnv vaccine |
06/09/1994 | WO1994002617A3 Cloning and expression of a lipase modulator gene from pseudomonas pseudoalcaligenes |
06/09/1994 | WO1994002508A3 Polypeptide antigens of mycobacterium bovis |
06/09/1994 | DE4240801A1 Staphylo-kinase (SAK) sequences lacking sequences for signal peptide(s) |
06/09/1994 | CA2592997A1 Pseudo-adenovirus vectors |
06/09/1994 | CA2151032A1 Activating expression of an amplifying endogenous gene by homologous recombination |
06/09/1994 | CA2150572A1 Nucleotide sequence encoding carbamoyl phosphate synthetase ii |
06/09/1994 | CA2150477A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
06/09/1994 | CA2150125A1 Cdna clone for human inducible nitric oxide synthase and process for preparing same |
06/09/1994 | CA2150117A1 Interleukin-3 (il-3) mutant polypeptides |
06/09/1994 | CA2150116A1 Interleukin-3 (il-3) multiple mutation polypeptides |
06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
06/09/1994 | CA2150027A1 Aids therapeutics based on hiv ma peptides |
06/09/1994 | CA2150025A1 Subtilin variant of enhanced stability and activity |
06/09/1994 | CA2149907A1 Oxalate decarboxylase |
06/09/1994 | CA2149889A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
06/09/1994 | CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
06/09/1994 | CA2149862A1 Multifunctional neurotrophic factors |
06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
06/09/1994 | CA2149025A1 Humanized antibodies reactive with l-selectin |
06/09/1994 | CA2148935A1 Purification of fusion proteins comprising gm-csf and il-3 |
06/09/1994 | CA2148929A1 Proteins having glycosyltransferase activity |
06/09/1994 | CA2145384A1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
06/09/1994 | CA2128705A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
06/09/1994 | CA2127807A1 Transgenic cotton plants producing heterologous bioplastic |
06/08/1994 | EP0600627A1 Human Id genes |
06/08/1994 | EP0600591A2 Inhibition of tumor cell growth by administration of B7-transfected cells |
06/08/1994 | EP0600463A2 Process for producing L-tryptophan, L-tyrosine or L-Phenylalanine |
06/08/1994 | EP0600372A1 Process for the preparation of proinsulin with correctly linked cystin bridges |
06/08/1994 | EP0600278A2 Glutamate receptor protein and gene coding the same |
06/08/1994 | EP0600253A1 Boron silicates, aluminum silicates, phosphosilicates and purification of DNA |
06/08/1994 | EP0600136A1 Intron/Exon structure of the human and mouse Beta 3 Adrenergic receptors genes |
06/08/1994 | EP0600018A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
06/08/1994 | EP0600009A1 Hepatitis c assay utilizing recombinant antigens to ns1 |
06/08/1994 | EP0600000A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
06/08/1994 | EP0599978A1 Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula |
06/08/1994 | EP0599971A1 Yeast promoter and use thereof |
06/08/1994 | EP0599945A1 Process for purposefully modifying the genetic characteristics of ashbya gossypii |
06/08/1994 | EP0599913A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
06/08/1994 | EP0599868A1 Polyphenol oxidase genes |
06/08/1994 | EP0599859A1 Mammalian pancreatic lipase and variant thereof |
06/08/1994 | EP0553287A4 Cytokine-induced marker for inflammatory response |
06/08/1994 | EP0553186A4 Method for producing t h?-independent cytotoxic t lymphocytes |
06/08/1994 | EP0533854A4 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
06/08/1994 | EP0531300B1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
06/08/1994 | EP0502011B1 Cloning method and kit |
06/08/1994 | EP0460041B1 Probes, kits and methods for the detection and differentiation of mycobacteria |
06/08/1994 | EP0407444B1 Apparatus and method for automated purification of extra-chromosomal dna from a cell suspension in a container |
06/08/1994 | EP0225887B1 A method and a hybrid promoter for controlling exogenous gene transcription |
06/08/1994 | CN1087681A Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
06/08/1994 | CA2110759A1 Process for producing riboflavin |
06/07/1994 | US5319073 Method of purifying cholecystokinin receptor protein |
06/07/1994 | US5319071 Soluble interleukin-1 receptors |
06/07/1994 | US5318905 Stable against alkaline conditions, anionic surfactants; deinking waste newspaper |
06/07/1994 | US5318900 Method for producing antiviral protein utilizing E. coli transformant, and gene and E. coli vector used in the method |
06/07/1994 | US5318899 Platelet aggregation inhibitors |
06/07/1994 | US5318898 Increasing yield by adding dextran sulfate to culture medium for transformed cells |
06/07/1994 | US5318897 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
06/07/1994 | US5318896 In situ expression of expandase gene; ring expansion of adipoyl-6-amino penicillanic acid; cleavage of adipoyl side chain |